MedPath

change in the level of blood immunity before and after epidural anesthesia in patients undergoing breast cancer surgery

Not Applicable
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Registration Number
CTRI/2022/01/039127
Lead Sponsor
Amrita Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA 2 patients who are scheduled for breast surgeries for breast cancer under epidural anaesthesia

Exclusion Criteria

1.Any contraindication for regional anaesthesia

2.Patients who have difficulty in lying down supine

3.Uncooperative/ Psychiatric patients

4.Endocrinological diseases

5.Immunological diseases

6.Chronic liver disease

7.Chronic pain

8.Signs of infection

9.Allergic to any of the study medication

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the change in proinflammatory mediator IL6 before and after epidural anaesthesiaTimepoint: Before and 2 hours after anaesthesia
Secondary Outcome Measures
NameTimeMethod
To assess the change in serum levels of TNF α, IL1β, IL10, IFN γ, IL 2, leucocytes, lymphocytes, neutrophils, monocytes, eosinophils and basophils caused by induction of epidural anaesthesia.Timepoint: Before and 2 hours after anaesthesia
© Copyright 2025. All Rights Reserved by MedPath